The FDA chief must not be a proxy for industry
- PMID: 28332541
- DOI: 10.1038/nature.2017.21661
The FDA chief must not be a proxy for industry
Comment on
-
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.N Engl J Med. 2014 May 8;370(19):1809-19. doi: 10.1056/NEJMoa1316222. Epub 2014 Mar 29. N Engl J Med. 2014. PMID: 24678979 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources